Inotiv Inc (NOTV)
4.27
+0.11
(+2.64%)
USD |
NASDAQ |
May 03, 16:00
4.27
0.00 (0.00%)
After-Hours: 20:00
Inotiv Cash from Financing (Quarterly): -2.921M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.921M |
| September 30, 2023 | -0.31M |
| June 30, 2023 | -1.042M |
| March 31, 2023 | -1.16M |
| December 31, 2022 | 18.38M |
| September 30, 2022 | 13.99M |
| June 30, 2022 | -1.369M |
| March 31, 2022 | 71.06M |
| December 31, 2021 | 119.47M |
| September 30, 2021 | 134.57M |
| June 30, 2021 | 65.58M |
| March 31, 2021 | -0.892M |
| December 31, 2020 | -0.429M |
| September 30, 2020 | -0.209M |
| June 30, 2020 | 3.253M |
| March 31, 2020 | 2.048M |
| December 31, 2019 | 4.549M |
| September 30, 2019 | 2.238M |
| June 30, 2019 | 2.913M |
| March 31, 2019 | 1.327M |
| December 31, 2018 | -0.273M |
| September 30, 2018 | 5.188M |
| June 30, 2018 | -0.089M |
| March 31, 2018 | -0.087M |
| December 31, 2017 | -0.086M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.337M |
| June 30, 2017 | -0.136M |
| March 31, 2017 | 0.632M |
| December 31, 2016 | -1.008M |
| September 30, 2016 | -0.477M |
| June 30, 2016 | 0.10M |
| March 31, 2016 | 0.042M |
| December 31, 2015 | 0.479M |
| September 30, 2015 | -0.208M |
| June 30, 2015 | -0.259M |
| March 31, 2015 | -0.753M |
| December 31, 2014 | 0.007M |
| September 30, 2014 | -0.139M |
| June 30, 2014 | 0.372M |
| March 31, 2014 | -0.324M |
| December 31, 2013 | -1.422M |
| September 30, 2013 | 0.869M |
| June 30, 2013 | -0.75M |
| March 31, 2013 | -0.378M |
| December 31, 2012 | -0.763M |
| September 30, 2012 | -0.025M |
| June 30, 2012 | -0.204M |
| March 31, 2012 | -0.503M |
| December 31, 2011 | -0.432M |
| September 30, 2011 | -0.494M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.921M
Minimum
Dec 2023
134.57M
Maximum
Sep 2021
22.62M
Average
2.238M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Avid Bioservices Inc | 0.085M |
| Macrogenics Inc | 0.273M |
| Synlogic Inc | 19.58M |
| BioXcel Therapeutics Inc | 2.123M |
| IGM Biosciences Inc | 0.402M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.545M |
| Cash from Investing (Quarterly) | -4.043M |
| Free Cash Flow | 4.042M |
| Free Cash Flow Per Share (Quarterly) | -0.4703 |
| Free Cash Flow to Equity (Quarterly) | -13.71M |
| Free Cash Flow to Firm (Quarterly) | 1.302M |
| Free Cash Flow Yield | 3.68% |